VERNA TAN: Open Payments
NPI 1174863971 · LIVERMORE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,757 in 137 payments from 18 companies in 2025. Trend: 2023 $1,749 · 2024 $3,003 · 2025 $2,757
Food & beverage: $2,483Education: $274
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $352 |
| ABBVIE INC. | 17 | $288 |
| Incyte Corporation | 16 | $282 |
| Lilly USA, LLC | 12 | $278 |
| Regeneron Healthcare Solutions, Inc. | 11 | $239 |
| Galderma Laboratories, L.P. | 20 | $230 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $220 |
| Arcutis Biotherapeutics, Inc. | 12 | $195 |
| UCB, Inc. | 11 | $192 |
| PFIZER INC. | 5 | $98 |
Products named: TREMFYA, DUPIXENT, OPZELURA, TALTZ, SKYRIZI, NEMLUVIO, Zoryve, Bimzelx.
Industry payments across CA — which companies pay providers there.
